Right heart remodeling after bicaval TricValve implantation in patients with severe tricuspid regurgitation.
From 16 to 19 May 2023, the specific program of P+F Products + Features GmbH in the forthcoming Euro PCR 2023 will be held at the Palais des Congrès in Paris.
Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative evaluation and patient selection.
Untreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When surgical correction is not feasible due to high operative risk, transcatheter tricuspid valve treatment has been suggested as an attractive value option.
The NOBLESTICH EL system produced by Nobles Medical Technology II USA, used by Umberto I of Rome.